0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Other Articles |

Recent Advances in Chemotherapy. Volume I

JAMA. 1950;144(15):1319. doi:10.1001/jama.1950.02920150093039.
Text Size: A A A
Published online

ABSTRACT

When the first edition of this work was published 20 years ago, chemotherapy, with the exception of antisyphilitic therapy, was confined largely to tropical diseases. Since then, the discovery of the sulfonamides and the antibiotics has removed this subject from the realm of the esoteric to a place of major importance in therapeutics. As evidence of the increased scope of chemotherapy, it may be noted that the first edition of this work occupied a single volume; the present edition, when completed, will encompass four. This volume may be considered as a revision of earlier ones, since it is confined to the chemotherapy of protozoan diseases, the majority of which are tropical in origin. The diseases discussed are those due to insects (principally scabies), to helminthic infestations (amebiasis, leishmaniasis, trypanosomiasis) and to various protozoa (babesiasis, bartonellosis, toxoplasmosis, coccidiosis and trichomoniasis). The pharmacology of the agents discussed is adequately reviewed, and the

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

* * SCHEDULED MAINTENANCE * *

Our websites may be periodically unavailable between midnight and 04:00 ET Thursday, July 10th, for regularly scheduled maintenance.

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();